Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Based on the clinical trial population and the medications mechanism, individuals who may benefit most from retatrutide once it becomes available include: Adults with a BMI of 30 or greater (obesity) Adults with a BMI of 27 or greater who have weight-related conditions such as type 2 diabetes, hypertension, dyslipidemia, or sleep apnea Individuals who have not achieved adequate results with semaglutide or tirzepatide Patients seeking greater weight loss than what current medications provide Individuals with metabolic dysfunction-associated steatohepatitis (MASH) given the glucagon receptors role in liver fat metabolism Retatrutide may not be appropriate for individuals with a history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, severe gastrointestinal disorders, or a history of pancreatitis
Doctors can see more patients without sacrificing the quality of care or increasing stress for the team, improving efficiency, results, and revenue
It was important to me that they had a real location
When paired with lifestyle changes like healthy eating and exercise, semaglutide can help patients achieve safe, consistent, and long-lasting weight loss
HigginsRDRajuTEdwardsADAzzopardiDVBoseCLClarkRHet al
US$ 29.47
US$ 20.79
US$ 20.81
US$ 27.27
